Furthermore, several immune molecules, such as cytotoxic T cell lymphocyte antigen 4 (CTLA4) and CD40 (TNF receptor superfamily 5), have been targeted clinically in osteosarcoma. The gene discussed is CD40; the disease is osteosarcoma.